Delayed-release capsules for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) or other conditions. Zenpep is the only FDA-approved pancreatic enzyme product (PEP) that has been evaluated in clinical studies in adults and children—including children from one to 12 years old—and will offer four dosage strengths to meet the varied needs of infants, toddlers, adolescents and adults with EPI.